The National Cancer Institute (NCI) has introduced predoctoral F30 fellowship support for dual degree MD/PhD, DO/PhD candidates. Students training in cancer biology may now apply for these prestigious F30 fellowships awarded through the NCI.
During the time leading up to this change, APSA supported several efforts to increase F30 funding to MD/PhD, DO/PhD trainees, including sponsoring a large MD/PhD, DO/PhD student survey that focused on funding opportunities and identifying shortfalls in funding.
Importantly, increasing F30 funding remains to be one of APSA's top initiatives: Even with NCI's participation, only 11/27 NIH institutes/centers fund the F30 fellowship. APSA will continue its efforts to encourage the participation of all NIH institutes in the F30 funding mechanism.